These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22951216)

  • 81. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antiprothrombin antibody: why do we need more assays?
    Atsumi T; Koike T
    Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Laboratory examinations in antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D; Boutière B; Sanmarco M
    Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland].
    Skrzypczak J; Rajewski M; Wirstlein P; Goździewicz T; Zimmer M; Wołczyński S; Leszczyńska-Gorzelak B; Breborowicz G; Ludwikowski G
    Ginekol Pol; 2011 Oct; 82(10):749-54. PubMed ID: 22379938
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Antiphospholipid syndrome in autoimmune diseases].
    Swadźba J; Iwaniec T; Wilańska J; Musiał J
    Pol Arch Med Wewn; 2006 May; 115(5):432-7. PubMed ID: 17195356
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevalence of anticardiolipin and anti-beta2-glycoprotein I antibodies in celiac disease.
    Karoui S; Sellami MK; Laatar AB; Zitouni M; Matri S; Laadhar L; Fekih M; Boubaker J; Makni S; Filali A
    Dig Dis Sci; 2007 Apr; 52(4):1096-100. PubMed ID: 17318386
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Antiphospholipid syndrome : Update on diagnostics and management].
    Specker C; Fischer-Betz R; Dörner T
    Z Rheumatol; 2020 Apr; 79(3):255-266. PubMed ID: 32185464
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
    Filippidou N; Krashias G; Pericleous C; Rahman A; Ioannou Y; Giles I; Demetriou C; Anatolitou A; Christodoulou C; Pantzaris M; Lambrianides A
    Mol Immunol; 2016 Jul; 75():161-7. PubMed ID: 27289032
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome.
    Ruiz-García R; Serrano M; Martínez-Flores JÁ; Mora S; Morillas L; Martín-Mola MÁ; Morales JM; Paz-Artal E; Serrano A
    J Immunol Res; 2014; 2014():704395. PubMed ID: 24741618
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Antiphospholipid antibodies in practice].
    Miyara M; Diemert MC; Amoura Z; Musset L
    Rev Med Interne; 2012 Apr; 33(4):176-80. PubMed ID: 22100197
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome.
    Micheloud D; Sánchez-Ramón S; Carbone J; Rodríguez Molina JJ; Fernández-Cruz E; López-Longo FJ; Rodríguez-Mahou M
    Clin Exp Rheumatol; 2005; 23(4):525-8. PubMed ID: 16095124
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anti-beta 2 glycoprotein 1 domain IgA positive antiphospholipid syndrome secondary to incomplete Behcet's disease: a case report.
    Dai L; Chen J; Chen Z; Zhu S; Zhang Y; Geng Y; Gu Z
    Ann Palliat Med; 2021 Jun; 10(6):7114-7120. PubMed ID: 34118834
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
    Tincani A; Andreoli L; Casu C; Cattaneo R; Meroni P
    Lupus; 2010 Apr; 19(4):432-5. PubMed ID: 20353983
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Jun; 34(4):361-72. PubMed ID: 18814070
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome.
    Bećarević M
    J Thromb Thrombolysis; 2016 Nov; 42(4):552-7. PubMed ID: 27307251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.